BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 14692611)

  • 1. Fatty acid metabolism in obesity and type 2 diabetes mellitus.
    Blaak EE
    Proc Nutr Soc; 2003 Aug; 62(3):753-60. PubMed ID: 14692611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus.
    Blaak EE
    Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance.
    Blaak EE
    Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity.
    Jocken JW; Blaak EE
    Physiol Behav; 2008 May; 94(2):219-30. PubMed ID: 18262211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Net release of individual fatty acids from white adipose tissue during lipolysis in vitro: evidence for selective fatty acid re-uptake.
    Raclot T; Oudart H
    Biochem J; 2000 May; 348 Pt 1(Pt 1):129-36. PubMed ID: 10794723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
    Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle.
    Corpeleijn E; Saris WH; Blaak EE
    Obes Rev; 2009 Mar; 10(2):178-93. PubMed ID: 19207879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism, exercise and insulin action.
    Bonen A; Dohm GL; van Loon LJ
    Essays Biochem; 2006; 42():47-59. PubMed ID: 17144879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW; Cooney GJ
    Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat as a fuel: emerging understanding of the adipose tissue-skeletal muscle axis.
    Frayn KN
    Acta Physiol (Oxf); 2010 Aug; 199(4):509-18. PubMed ID: 20353493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term pioglitazone treatment enhances lipolysis in rat adipose tissue.
    Pravenec M; Kazdová L; Maxová M; Zídek V; Mlejnek P; Simáková M; Kurtz TW
    Int J Obes (Lond); 2008 Dec; 32(12):1848-53. PubMed ID: 18936763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.
    Lafontan M; Moro C; Sengenes C; Galitzky J; Crampes F; Berlan M
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2032-42. PubMed ID: 16123323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids and insulin resistance.
    Delarue J; Magnan C
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological regulation of NEFA availability: lipolysis pathway.
    Stich V; Berlan M
    Proc Nutr Soc; 2004 May; 63(2):369-74. PubMed ID: 15294057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in Pima Indians. A combined effect of genetic predisposition and obesity-related skeletal muscle cell hypertrophy.
    Lillioja S; Bogardus C
    Acta Med Scand Suppl; 1988; 723():103-19. PubMed ID: 3134799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
    Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
    Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes, lipids, and adipocyte secretagogues.
    Faraj M; Lu HL; Cianflone K
    Biochem Cell Biol; 2004 Feb; 82(1):170-90. PubMed ID: 15052336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance: the role of intramuscular triglyceride and the importance of physical activity].
    Timmermans RJ; Saris WH; van Loon LJ
    Ned Tijdschr Geneeskd; 2006 Jan; 150(3):122-7. PubMed ID: 16463611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.